JPMORGAN CHASE & CO - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 88 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$177,251
-32.2%
32,523
-15.6%
0.00%
Q2 2023$261,571
-73.3%
38,523
-80.3%
0.00%
Q1 2023$979,000
+611775.0%
195,435
+498.0%
0.00%
Q4 2022$160
-100.0%
32,683
-3.8%
0.00%
Q3 2022$491,000
-0.6%
33,979
+4.0%
0.00%
Q2 2022$494,000
-1.8%
32,664
-22.8%
0.00%
Q1 2022$503,000
-17.5%
42,322
+12.6%
0.00%
Q4 2021$610,000
-40.4%
37,570
+4.7%
0.00%
Q3 2021$1,024,000
-14.5%
35,880
+1.3%
0.00%
Q2 2021$1,198,000
+24.1%
35,419
+11.0%
0.00%
Q1 2021$965,000
-35.1%
31,916
+6.4%
0.00%
Q4 2020$1,486,000
+23.6%
30,007
+1.1%
0.00%
Q3 2020$1,202,000
-11.4%
29,682
-5.6%
0.00%
Q2 2020$1,357,000
+60.2%
31,436
-3.2%
0.00%
Q1 2020$847,000
-20.8%
32,471
-5.1%
0.00%
Q4 2019$1,070,000
+16.7%
34,233
-2.7%
0.00%
Q3 2019$917,000
+24.1%
35,196
+6.0%
0.00%
Q2 2019$739,000
-6.2%
33,189
+10.4%
0.00%
Q1 2019$788,000
+23.7%
30,074
-4.0%
0.00%
Q4 2018$637,000
-20.2%
31,323
+4.3%
0.00%
Q3 2018$798,00030,0250.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$1,041,9094.24%
Sofinnova Investments, Inc. 2,194,278$11,958,8150.75%
DENALI ADVISORS LLC 85,900$468,1550.16%
Polar Capital Holdings Plc 2,103,298$11,462,9740.08%
Soleus Capital Management, L.P. 157,182$856,6420.08%
GSA CAPITAL PARTNERS LLP 137,299$7480.06%
Caligan Partners LP 23,321$127,0990.06%
Corton Capital Inc. 12,244$66,7300.03%
RICE HALL JAMES & ASSOCIATES, LLC 91,249$497,3070.03%
CIM INVESTMENT MANAGEMENT INC 15,313$83,4560.03%
View complete list of Y-MABS THERAPEUTICS INC shareholders